Astellas has set a goal of achieving net-zero greenhouse gas (GHG) emissions by 2050. The company has a long history of sustainability initiatives, and this latest target is a significant step forward in its commitment to environmental responsibility.
Astellas has already taken a number of steps to reduce its GHG emissions. In 2015, the company set a goal of reducing its emissions by 30% by 2030. It has since made progress towards this goal, and it is on track to meet it.
In order to achieve net-zero emissions by 2050, Astellas will need to take more ambitious steps. The company plans to invest in renewable energy, energy efficiency, and other technologies that will help it reduce its emissions. It is also working with its suppliers and partners to reduce the environmental impact of its operations.
Astellas is committed to transparency in its sustainability reporting. The company publishes an annual sustainability report that details its progress on environmental, social, and governance (ESG) initiatives. The company also participates in a number of sustainability initiatives, such as the Science Based Targets initiative (SBTi).
Astellas has published a Modern Slavery Statement in accordance with the UK Modern Slavery Act 2015. The statement outlines the company's commitment to combating modern slavery and human trafficking in its own operations and supply chains.
Astellas has a number of policies and procedures in place to prevent modern slavery and human trafficking, including a code of conduct that prohibits forced labor, child labor, and other forms of modern slavery. The company also has a supplier due diligence process that assesses the risk of modern slavery in Astellas' supply chains. In addition, Astellas has a whistleblowing hotline that employees can use to report suspected cases of modern slavery.
Astellas works with a number of organizations to combat modern slavery, including the Walk Free Foundation and the Ethical Trading Initiative. In 2021, Astellas joined the Fashion Transparency Index, which is a global initiative that aims to increase transparency in the fashion industry's supply chains.
Astellas is committed to continuous improvement in its efforts to combat modern slavery. The company conducts regular assessments of its risk exposure and takes steps to mitigate any identified risks. Astellas also publishes an annual Modern Slavery Statement to report on its progress in this area.
Astellas Pharma Inc. is a Japanese pharmaceutical company that is committed to creating an inclusive workplace for all employees. The company has a number of policies and programs in place to promote inclusion, including a diversity and inclusion council, a mentorship program, and a training program that teaches employees about unconscious bias and how to create a more inclusive workplace.
Astellas also works with a number of external organizations to promote inclusion, such as the World Economic Forum's Global Council on Diversity and Inclusion and the Human Rights Campaign. In 2021, Astellas was named one of the "Best Places to Work for LGBTQ+ Equality" by the Human Rights Campaign.
In addition to its policies and programs, Astellas also actively practices inclusion in its everyday operations. For example, the company's leadership team is made up of people from diverse backgrounds, and the company's marketing materials feature a variety of different people. Astellas also makes a point of hiring and promoting employees from underrepresented groups.
Astellas' commitment to inclusion is an important part of its corporate social responsibility (CSR) strategy. The company believes that it has a responsibility to create a workplace where everyone feels welcome and valued. Astellas is also committed to using its influence to promote inclusion in the wider community.
Astellas is committed to engaging with its communities. The company believes that it has a responsibility to give back to the communities where it operates and to make a positive impact on the lives of the people who live there.
Astellas engages with its communities in a variety of ways. For example, it donates money and resources to local charities and organizations. In 2021, Astellas donated $1 million to the American Red Cross to help with relief efforts in the wake of Hurricane Ida. Astellas also volunteers the time and skills of its employees. Astellas employees volunteer in their communities in a variety of ways, such as tutoring students, working at soup kitchens, and cleaning up parks. Additionally, Astellas partners with local organizations to address community needs. For example, Astellas partners with the United Way to provide financial assistance to families in need. Finally, Astellas offers a variety of educational programs and resources to the community. These programs and resources cover topics such as health and wellness, financial literacy, and job training.
by Astellas
Pharmaceuticals Evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (CKD)
Supplies to Every ContinentDesigned in JapanMade in Japan
by Astellas
Certification
FDA CCP
Manufacturer
by Astellas
Pharmaceuticals PADCEV can be used by itself or together with pembrolizumab (Keytruda®) to treat advanced* bladder cancer and cancers of the urinary tract (renal pelvis, ureter, or urethra).
Supplies to Every ContinentDesigned in JapanMade in Japan
by Astellas
Certification
FDA CCP
Manufacturer
by Astellas
Pharmaceuticals XOSPATA was studied in people with FLT3m+ AML when the disease had come back or had not improved after previous treatment. The study compared overall survival in people who had taken XOSPATA vs those who received chemotherapy. In the study, the median overall survival for people who took XOSPATA was 9 months vs 6 months with chemotherapy.
Supplies to Every ContinentDesigned in JapanMade in Japan
by Astellas
Certification
FDA CCP
Manufacturer
by Astellas
Pharmaceuticals XTANDI (enzalutamide) is a prescription medicine used to treat men with prostate cancer that: no longer responds to a hormone therapy or surgical treatment to lower testosterone OR has spread to other parts of the body and responds to a hormone therapy or surgical treatment to lower testosterone.
Supplies to Every ContinentDesigned in JapanMade in Japan
by Astellas
Certification
FDA CCP
Manufacturer
Get new company profiles every week!